SANUWAVE Health Inc
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
SNWV$1.88+1.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows for the
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Cash Flows - Operating Activities: | ||
| Net Loss | $(18,624) | $(44,042) |
| Adjustments to reconcile net loss to net cash used by operating activities | ||
| Depreciation and amortization | 736 | 780 |
| Bad debt expense | 16 | 547 |
| Shares issued for services | - | 224 |
| Gain on extinguishment of debt | (5,205) | - |
| Change in fair value of derivative liabilities | 17,633 | 29,943 |
| Amortization of debt issuance costs and original issue discount | 4,792 | 5,656 |
| Accrued interest | 2,749 | 5,529 |
| Changes in operating assets and liabilities | ||
| Accounts receivable | 66 | 253 |
| Inventory | (480) | (844) |
| Prepaid expenses and other assets | 225 | (487) |
| Accounts payable | (1,013) | 464 |
| Accrued expenses | 763 | (1,326) |
| Contract liabilities | 56 | 50 |
| Net Cash Provided by (Used in) Operating Activities | 1,714 | (3,253) |
| Cash Flows - Investing Activities | ||
| Proceeds from sale of property and equipment | - | 13 |
| Purchase of property and equipment | (254) | (169) |
| Net Cash Flows Used in Investing Activities | (254) | (156) |
| Cash Flows - Financing Activities | ||
| Proceeds from convertible promissory notes | - | 1,202 |
| Payment of note payable | (2,175) | - |
| Proceeds from convertible notes payable | 1,300 | - |
| Proceeds from promissory note payable, related party | 500 | - |
| Proceeds from bridge notes advance | - | 2,994 |
| Proceeds (Payments) from factoring, net | 449 | (710) |
| Payments of principal on finance leases | (193) | (130) |
| Net Cash Flow (Used in) Provided by Financing Activities | (119) | 3,356 |
| Effect of Exchange Rates on Cash | 121 | (5) |
| Net Change in Cash During Period | 1,462 | (58) |
| Cash at Beginning of Period | 1,797 | 1,153 |
| Cash at End of Period | $3,259 | $1,095 |
| Supplemental Information: | ||
| Cash paid for interest | $3,189 | $984 |
| Non-cash Investing and Financing Activities: | ||
| Shares issued for settlement of debt | 1,412 | - |
| Write off deferred merger costs | 1,226 | - |
| Warrants issued in conjunction with convertible promissory notes | 3,633 | 570 |
| Conversion of convertible notes payable to common stock | - | 18,577 |
| Capitalize default interest into senior secured debt | 3,850 | - |
| Conversion of asset-based secured promissory notes to convertible promissory notes | 4,584 | - |
| Embedded conversion feature on convertible promissory notes payable | - | (520) |
| Common shares issued for advisory shares | - | 302 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.